AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.984
-0.056 (-5.35%)
Apr 28, 2026, 4:00 PM EDT - Market closed
AEON Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 25 | 13 | 22 | 268 | 1,395 | 214 | |
| Market Cap Growth | 491.21% | -39.67% | -91.93% | -80.82% | 553.24% | - | |
| Enterprise Value | 58 | 25 | 38 | 252 | 1,642 | 428 | |
| Last Close Price | 0.98 | 1.10 | 38.88 | 518.40 | 723.60 | 699.12 | |
| PE Ratio | - | - | 0.51 | - | - | - | |
| PB Ratio | - | -0.24 | -0.76 | -1.75 | -10.53 | -2.49 | |
| Debt / Equity Ratio | -0.65 | -0.65 | -0.45 | 0.00 | -0.99 | -1.01 | |
| Net Debt / Equity Ratio | -0.59 | -0.59 | -0.45 | 0.03 | -0.92 | -0.95 | |
| Net Debt / EBITDA Ratio | -2.02 | -2.02 | -0.47 | 0.09 | -2.52 | -2.22 | |
| Net Debt / FCF Ratio | -1.89 | -1.89 | -0.64 | 0.10 | -3.40 | -2.86 | |
| Quick Ratio | 0.44 | 0.44 | 0.00 | 0.40 | 0.12 | 0.25 | |
| Current Ratio | 0.49 | 0.49 | 0.11 | 0.48 | 0.12 | 0.25 | |
| Return on Assets (ROA) | -234.17% | -234.17% | -348.25% | -374.77% | -351.67% | -166.73% | |
| Return on Capital Employed (ROCE) | 1219.30% | 1219.30% | 252.80% | 851.60% | 67.50% | 256.70% | |
| Earnings Yield | -157.47% | -301.19% | 194.61% | -143.76% | -3.77% | -26.05% | |
| FCF Yield | -69.50% | -132.94% | -94.01% | -17.88% | -2.57% | -13.39% | |
| Buyback Yield / Dilution | -1622.66% | -1622.66% | 99.25% | -3896.62% | -9.98% | -1813.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.